These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468 [TBL] [Abstract][Full Text] [Related]
11. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899 [TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT; Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366 [TBL] [Abstract][Full Text] [Related]
15. Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement. D'Angelo E; Ali RH; Espinosa I; Lee CH; Huntsman DG; Gilks B; Prat J Am J Surg Pathol; 2013 Apr; 37(4):514-21. PubMed ID: 23211293 [TBL] [Abstract][Full Text] [Related]
16. Extrapelvic Metastases in Endometrial Stromal Sarcomas: A Clinicopathological Review With Immunohistochemical and Molecular Characterization. Baniak N; Adams S; Lee CH; Chibbar R; Kanthan R Int J Surg Pathol; 2019 Apr; 27(2):208-215. PubMed ID: 30124116 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study. Wang F; Dai X; Chen H; Hu X; Wang Y BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687 [TBL] [Abstract][Full Text] [Related]
18. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study. Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis. Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401 [TBL] [Abstract][Full Text] [Related]
20. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Rush DS; Tan J; Baergen RN; Soslow RA Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]